BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2417787)

  • 1. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract]   [Full Text] [Related]  

  • 2. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
    Lian LJ; Hu XF; Liu WS; Wu AJ
    Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA-125: An evaluation.
    Nuss R; Swor MG; Benrubi MD
    J Fla Med Assoc; 1987 May; 74(5):329-32. PubMed ID: 2440975
    [No Abstract]   [Full Text] [Related]  

  • 7. Coexpression of different antigenic markers on moieties that bear CA 125 determinants.
    Yu YH; Schlossman DM; Harrison CL; Rhinehardt-Clark A; Soper JT; Klug TL; Zurawski VR; Bast RC
    Cancer Res; 1991 Jan; 51(2):468-75. PubMed ID: 1702359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA 125 for the monitoring of ovarian carcinoma during primary therapy.
    Lavin PT; Knapp RC; Malkasian G; Whitney CW; Berek JC; Bast RC
    Obstet Gynecol; 1987 Feb; 69(2):223-7. PubMed ID: 2433652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.
    Davis HM; Zurawski VR; Bast RC; Klug TL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6143-8. PubMed ID: 2430690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications.
    Mainguené C; Aillet G; Kremer M; Chatal JF
    J Nucl Med Allied Sci; 1986; 30(1):19-22. PubMed ID: 3528419
    [No Abstract]   [Full Text] [Related]  

  • 12. CA 125 and TPA as markers in ovarian carcinoma.
    Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT
    Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigens associated with epithelial ovarian carcinomas.
    Bast RC
    Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody against human ovarian tumor-associated antigens.
    Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
    J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer: immunologic diagnosis and therapy.
    Barber HR; Dorsett B
    Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
    Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
    Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.